<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-COG-C-UNDP</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Project to improve the national response to HIV in the areas of prevention, care and support and to strengthen the response  to tuberculosis in Congo</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Congo - TB/HIV.  This program has the following goals: R&#xE9;duire de 50% les nouvelles infections parmi les populations vuln&#xE9;rables (en l&#x2019;occurrence les jeunes filles, les jeunes femmes), les populations cl&#xE9;s et &#xE9;liminer celles chez les enfants d&apos;ici &#xE0; 2023/Reduce new infections by 50% among vulnerable populations (young girls, young women), key populations and elimination among children by 2023.  R&#xE9;aliser les objectifs 90-90-90 en vue de r&#xE9;duire de mani&#xE8;re significative la morbidit&#xE9; et la mortalit&#xE9; chez les PVVIH  d&apos;au moins 62% d&apos;ici &#xE0; 2023/Achieve the 90-90-90 targets to significantly reduce morbidity and mortality among PLHIV by at least 62% by 2023.  R&#xE9;duire le nombre de d&#xE9;c&#xE8;s li&#xE9; &#xE0; la tuberculose de 35% &#xE0; l&apos;horizon 2023 par rapport &#xE0; l&apos;ann&#xE9;e 2015/Reduce the number of tuberculosis-related deaths by 35% by 2023 compared to 2015.  R&#xE9;duire l&apos;incidence de la tuberculose de 20% &#xE0; l&apos;horizon 2023 par rapport &#xE0; 2015/Reduce the incidence of tuberculosis by 20% by 2023 compared to 2015. The objectives of this program are: Augmenter la proportion des personnes vivant avec le VIH qui connaissent leur statut s&#xE9;rologique &#xE0; 65% en 2023/Increase the proportion of people living with HIV who know their HIV status to 65% between 2021 and 2023.  Augmenter la proportion des femmes enceintes s&#xE9;ropositives qui ont acc&#xE8;s &#xE0; la TAR &#xE0; 50 % d&apos;ici &#xE0; 2023/Increase the proportion of pregnant women with HIV who have access to ART to 50% by 2023.  Augmenter la proportion des personnes s&#xE9;ropositives qui ont acc&#xE8;s &#xE0; la TARV &#xE0; 40% d&apos;ici &#xE0; 2023/Increase the proportion of people living with HIV who have access to ART to 40% by 2023.  Augmenter la proportion des personnes sous TARV qui ont leur charge virale indetectable &#xE0; 70% d&apos;ici &#xE0; 2023/Increase the proportion of people on ART who have their undetectable viral load to 70% by 2023.  Accro&#xEE;tre de 20% d&apos;ici 2023 la notification de nouveaux cas et rechutes de tuberculose toutes formes par rapport &#xE0; 2015/Increase to 20% by 2023 the notification of new  and relapses cases of all forms of tuberculosis compared to 2015.  Atteindre 70% de taux de suc&#xE8;s th&#xE9;rapeutique chez les nouveaux cas et rechutes de tuberculose toutes formes d&apos;ici 2023/Achieve 70% treatment success rate in new  and relapses cases of all forms of tuberculosis by 2023.  Atteindre 80% de taux de succ&#xE8;s th&#xE9;rapeutique chez les malades multi-r&#xE9;sistants mis sous traitement de 2&#xE8;me ligne d&apos;ici 2023/Achieve 80% treatement success rate inMDR-TB patients on second line treatment by 2023</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Congo (Republic of)</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Congo (Republic of)</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="232cc9bb-9e26-4160-ab63-bd1026aa6e36" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="COG-C-UNDP" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-10-06" type="1"></activity-date>
  <activity-date iso-date="2020-10-06" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Sandrine LOURENCO</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>sandrine.lourenco@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Sandrine LOURENCO</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>sandrine.lourenco@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="CG" percentage="100">
   <narrative xml:lang="EN">Congo</narrative>
  </recipient-country>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">TB/HIV</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="0.73" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="4.1" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="2.02" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="15.29" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="D8A4C47C-BD32-4DDC-98CD-FDAE0FD2B520" percentage="28.83" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Pharmaceutical Products (HPPP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="9.12" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="8.27" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="0.65" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="1.72" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="2.57" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="2F782C08-F342-42A0-ABA7-BD8E9C920F54" percentage="0.2" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Payment for Results</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="12.02" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="14.5" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">8094380</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">2630853</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">1075054</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1181530</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">9453508</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">993808</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">838092</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1000970</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">8931323</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">890650</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">828105</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">940323</value>
  </budget>
  <capital-spend percentage="2.02"></capital-spend>
  <transaction ref="1feadb08-1225-4c73-b066-bcd01b48ee08">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-11"></transaction-date>
   <value currency="USD" value-date="2021-01-11">21267246.22</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to COG-C-UNDP.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="792c29f1-7a7a-405f-8845-4507e7ca349a">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-20"></transaction-date>
   <value currency="USD" value-date="2021-01-20">9131860.63</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to COG-C-UNDP.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
 </iati-activity>
</iati-activities>
